Pharmacy

The FINANCIAL -- Gilead Sciences, Inc. on August 1 announced that the U.S. Food and Drug Administration (FDA) has approved...

The FINANCIAL -- Amgen on July 31 announced the submission of a supplemental Biologics License Application (sBLA) to the U.S....

The FINANCIAL -- Sanofi Chief Executive Officer, Olivier Brandicourt, commented:

The FINANCIAL -- AbbVie announced financial results for the second quarter ended June 30, 2017.

The FINANCIAL -- Astellas Pharma Inc. on July 28 announced the financial results for the first quarter of fiscal year...

The FINANCIAL -- Gilead Sciences, Inc. on July 28 announced that the European Commission has granted marketing authorization for Vosevi...

The FINANCIAL -- Bristol-Myers Squibb Company on July 27 reported results for the second quarter of 2017 which were highlighted...

The FINANCIAL -- Commenting on the Group’s results, Roche CEO Severin Schwan said: “In the first half of the year,...

The FINANCIAL -- Merck, known as MSD outside the United States and Canada, on July 28 announced financial results for...

The FINANCIAL -- The Bayer Group’s performance in the second quarter of 2017 matched the prior-year period, despite the company...

The FINANCIAL -- AstraZeneca and Merck & Co., Inc., (Merck; known as MSD outside of the US and Canada) on...

The FINANCIAL -- Amgen on July 25 announced financial results for the second quarter of 2017. Key results include:

The FINANCIAL -- Eli Lilly and Company on July 25 announced financial results for the second quarter of 2017.

The FINANCIAL -- GlaxoSmithKline plc on July 25 announced that Karenann Terrell has been appointed Chief Digital & Technology Officer...

The FINANCIAL -- Biogen Inc. on July 25 reported second quarter 2017 financial results, including: